Positron emission tomography/computed tomography in locally advanced breast cancer
Locally advanced breast cancer (LABC) is a relatively small group of breast cancer, but is significant because it carries a higher risk of locoregional recurrence and distant metastasis. The accepted approach for these patients is neoadjuvant chemotherapy before surgery as determining the response t...
Збережено в:
| Дата: | 2013 |
|---|---|
| Автор: | |
| Формат: | Стаття |
| Мова: | English |
| Опубліковано: |
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
2013
|
| Назва видання: | Experimental Oncology |
| Теми: | |
| Онлайн доступ: | http://dspace.nbuv.gov.ua/handle/123456789/145235 |
| Теги: |
Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|
| Назва журналу: | Digital Library of Periodicals of National Academy of Sciences of Ukraine |
| Цитувати: | Positron emission tomography/computed tomography in locally advanced breast cancer / E. Ozkan // Experimental Oncology. — 2013. — Т. 35, № 4. — С. 253-257. — Бібліогр.: 52 назв. — англ. |
Репозитарії
Digital Library of Periodicals of National Academy of Sciences of Ukraine| id |
irk-123456789-145235 |
|---|---|
| record_format |
dspace |
| spelling |
irk-123456789-1452352019-01-20T01:23:40Z Positron emission tomography/computed tomography in locally advanced breast cancer Ozkan, E. Special issue on breast cancer Locally advanced breast cancer (LABC) is a relatively small group of breast cancer, but is significant because it carries a higher risk of locoregional recurrence and distant metastasis. The accepted approach for these patients is neoadjuvant chemotherapy before surgery as determining the response to therapy in the early stages is of critical importance in respect of the approach taken to the disease. Positron emission tomography/computed tomography (PET/CT) using fluorine-18-fluorodeoxyglucose (18F-FDG) is currently used for staging, restaging and response monitoring in breast cancer. The areas of use of FDG PET/CT in LABC can be summarised as the evaluation of response to neoadjuvant chemotherapy in the early stage in particular, and the determination of unexpected areas of metastasis not detected by standard imaging techniques. There are current ongoing studies on promising new PET radiopharmaceuticals apart from FDG. 2013 Article Positron emission tomography/computed tomography in locally advanced breast cancer / E. Ozkan // Experimental Oncology. — 2013. — Т. 35, № 4. — С. 253-257. — Бібліогр.: 52 назв. — англ. 1812-9269 http://dspace.nbuv.gov.ua/handle/123456789/145235 en Experimental Oncology Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України |
| institution |
Digital Library of Periodicals of National Academy of Sciences of Ukraine |
| collection |
DSpace DC |
| language |
English |
| topic |
Special issue on breast cancer Special issue on breast cancer |
| spellingShingle |
Special issue on breast cancer Special issue on breast cancer Ozkan, E. Positron emission tomography/computed tomography in locally advanced breast cancer Experimental Oncology |
| description |
Locally advanced breast cancer (LABC) is a relatively small group of breast cancer, but is significant because it carries a higher risk of locoregional recurrence and distant metastasis. The accepted approach for these patients is neoadjuvant chemotherapy before surgery as determining the response to therapy in the early stages is of critical importance in respect of the approach taken to the disease. Positron emission tomography/computed tomography (PET/CT) using fluorine-18-fluorodeoxyglucose (18F-FDG) is currently used for staging, restaging and response monitoring in breast cancer. The areas of use of FDG PET/CT in LABC can be summarised as the evaluation of response to neoadjuvant chemotherapy in the early stage in particular, and the determination of unexpected areas of metastasis not detected by standard imaging techniques. There are current ongoing studies on promising new PET radiopharmaceuticals apart from FDG. |
| format |
Article |
| author |
Ozkan, E. |
| author_facet |
Ozkan, E. |
| author_sort |
Ozkan, E. |
| title |
Positron emission tomography/computed tomography in locally advanced breast cancer |
| title_short |
Positron emission tomography/computed tomography in locally advanced breast cancer |
| title_full |
Positron emission tomography/computed tomography in locally advanced breast cancer |
| title_fullStr |
Positron emission tomography/computed tomography in locally advanced breast cancer |
| title_full_unstemmed |
Positron emission tomography/computed tomography in locally advanced breast cancer |
| title_sort |
positron emission tomography/computed tomography in locally advanced breast cancer |
| publisher |
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України |
| publishDate |
2013 |
| topic_facet |
Special issue on breast cancer |
| url |
http://dspace.nbuv.gov.ua/handle/123456789/145235 |
| citation_txt |
Positron emission tomography/computed tomography in locally advanced breast cancer / E. Ozkan // Experimental Oncology. — 2013. — Т. 35, № 4. — С. 253-257. — Бібліогр.: 52 назв. — англ. |
| series |
Experimental Oncology |
| work_keys_str_mv |
AT ozkane positronemissiontomographycomputedtomographyinlocallyadvancedbreastcancer |
| first_indexed |
2023-05-20T17:21:36Z |
| last_indexed |
2023-05-20T17:21:36Z |
| _version_ |
1796153117507584000 |